Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Central Nervous System Diseases × sagopilone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasm Metastasis 1 Central Nervous System Diseases 1 Brain Neoplasms 1

Interventions

Trastuzumab 2 tucatinib 1 sagopilone 1 pembrolizumab 1 glutathione pegylated liposomal doxorubicin 1 elacestrant 1 abemaciclib 1 RAD1901 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00496379 2013-03-14

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Dana-Farber Cancer Institute

Phase 2 Terminated

15 enrolled 10 charts

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡